Jan H.M. Schellens
University of Applied Sciences Utrecht(NL)Utrecht University(NL)The Netherlands Cancer Institute(NL)Oncode Institute(NL)Pharmo Institute(NL)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Drug Transport and Resistance Mechanisms, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers(2009)3,610 cited
- → Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer(2019)1,423 cited
- Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.(2001)
- → Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval(2010)988 cited
- → Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer(2017)859 cited
- → A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent(2004)820 cited